VTR
Ventas
Real Estate · Health Care REITs · US
$82.02
Data: 2025-12-31
✗ ETHICAL FAIL

WEAK MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$42.4B
Total market value of the company
Trailing P/E
158.70
Expensive — high growth expected
Forward P/E
96.20
Based on estimated future earnings — lower means cheaper
Rev Growth
+21.9%
Year-over-year revenue change
Profit Margin
0.0%
How much profit the company keeps from each dollar of revenue
ROE
2.1%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$95.40
+16% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 20 analysts covering this stock
About Ventas

Ventas, Inc. is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 850 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OI platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives. Ventas, Inc. was incorporated in 1983 and is based in Chicago, United States.

https://www.ventasreit.com

Country: United States Employees: 542 Industry: REIT - Healthcare Facilities
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
47.9% FAIL
Debt must be below 33% of total assets
Cash Ratio
2.6% PASS
Interest-bearing cash below 33% of assets
Receivables
3.6% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
Fair Value Est.
$23.00
What our model estimates this business is worth per share
Margin of Safety
-256.6%
Trading above fair value — no margin of safety
Rating
AVOID
Overall assessment combining ethics, valuation, and quality
Percentile
1.9th
Ranks in the top 98% of our 13,571 screened universe
Ethical Score
10.0
Valuation Score
16.5
Quality Score
41.8
Combined
22.7

Trading at $87, 279% above fair value of $23. Fails ethical screen (Debt ratio). Ranks better than 5% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime
MARKUP
Price trending up with increasing momentum
Sharpe Ratio
1.800
Excellent risk-adjusted returns
Kelly Fraction
0.1388
Suggested allocation is meaningful — the edge justifies a position
Calmar Ratio
3.001
Returns exceed worst-case losses — strong risk profile
Annual Return
41.3%
Historical annualised return based on price data
Max Drawdown
-13.8%
Largest peak-to-trough decline — the worst it has been
HMM State
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
141
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

Beta
0.76
Less volatile than the market — more defensive
52W High
$90.99
10% below the year high
52W Low
$61.76
33% above the year low
Avg Volume
3,804,961
Average daily shares traded — higher means easier to buy and sell
Short Ratio
4.7
Days it would take all short sellers to cover — higher means more crowded
Short % Float
4.7%
Low short interest — limited bearish positioning
Div Yield
238.0%
Annual dividend as a percentage of the share price
EPS (TTM)
$0.55
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity
0.94
Moderate leverage — manageable
Current Ratio
0.21
Below 1 means short-term obligations exceed liquid assets — risk flag
Quick Ratio
0.19
Like current ratio but excludes inventory — stricter test
Gross Margin
40.5%
Revenue left after cost of goods — higher means pricing power
Operating Margin
13.8%
Profit from core operations before interest and tax
Free Cash Flow
$1.5B
Positive — the business generates more cash than it spends
Revenue (TTM)
$6.1B
Total revenue over the last 12 months
Net Income
$260M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
20
Target High
$102.00
Target Median
$95.40
Target Low
$86.00
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

Date Insider Title Type Shares Value
2026-05-14 RAKOWICH WALTER C. Director 1,152 $103,915
2026-05-13 BIGMAN THEODORE R. Director 2,047 $184,946
2026-05-13 RAKOWICH WALTER C. Director 2,047 $184,946
2026-05-13 SMITH MAURICE S Director 2,047 $184,946
2026-05-13 RODRIGUEZ JOE VASQUEZ JR. Director 2,047 $184,946
2026-05-13 ROY SUMIT Director 2,047 $184,946
2026-05-13 NOLAN SEAN PATRICK Director 2,047 $184,946
2026-05-13 BARNES MELODY C Director 2,047 $184,946
2026-05-13 MARTINO ROXANNE M. Director 2,047 $184,946
2026-05-13 NADER MARGUERITE M Director 2,047 $184,946
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2025-12-31

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry Indicators Options Calendar Composites Boycott Tracker Is It Halal? Earnings Calendar Dividend Screener Country Guides Glossary Join Free →

Get our weekly market brief free.